================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
AMENDMENT NO. 2
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1998
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 000-21930
BIOSOURCE INTERNATIONAL, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 77-0340829
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
820 FLYNN ROAD
CAMARILLO, CALIFORNIA 93102
(Address of principal executive offices and zip code)
(805) 383-5200
(Registrant's telephone number, including area code)
SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
NONE
SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:
Common stock, $.001 par value
Preferred Stock Purchase Rights
Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No .
---- ----
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any Amendment to this
Form 10-K. [ ]
The aggregate market value of the voting stock (based on the last sale
price of such stock as reported by the National Association of Securities
Dealers Automated Quotation National Market System) held by non-affiliates of
the registrant as of March 31, 1999 was $26,317,000.
The number of shares of the Registrant's common stock outstanding as of
March 31, 1999 was 7,181,925.
DOCUMENTS INCORPORATED BY REFERENCE
None.
================================================================================
<PAGE>
EXHIBIT 21
SUBSIDIARIES OF THE COMPANY
NAME STATE/COUNTRY OF INCORPORATION
Keystone Laboratories, Inc...................... California
BioSource V.I. FSC., LTD........................ U.S. Virgin Islands
BioSource Europe, S.A........................... Belguim
BioSource France sarl....................... France
BioSource B.V............................... Holland
BioSource Gmbh.............................. Germany
Medgenix Diagnostici Italia, srl............ Italy
BioSource U.K., Ltd......................... U.K.
Quality Controlled Biochemicals, Inc............ Massachusetts
Javelle, Inc................................ Massachusetts
Page 2
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15 (d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned, thereunto duly authorized.
BIOSOURCE INTERNATIONAL, INC.
Date: June 13, 2000 By: /S/ JAMES H. CHAMBERLAIN
------------------------------
James H. Chamberlain
CHAIRMAN AND
CHIEF EXECUTIVE OFFICER
Date: June 13, 2000 By: /S/ CHARLES C. BEST
-----------------------------
Charles C. Best
CHIEF FINANCIAL OFFICER
In accordance with the Exchange Act, this report has been signed below by
the following person on behalf of the registrant and in the capacities and on
the date indicated:
SIGNATURE TITLE DATE
/S/ JAMES H. CHAMBERLAIN Chairman, Chief Executive June 13, 2000
------------------------------ Officer, and Director
James H. Chamberlain
/S/ CHARLES C. BEST Chief Financial Officer, June 13, 2000
------------------------------ Principal Accounting Officer
Charles C. Best
/S/ JEAN-PIERRE L. CONTE Director June 13, 2000
------------------------------
Jean-Pierre L. Conte
Director
------------------------------
Leonard M. Hendrickson
Director
------------------------------
David J. Moffa, Ph.D.
/S/ JOHN R. OVERTURF, JR. Director June 13, 2000
------------------------------
John R. Overturf, Jr.
Director
------------------------------
Robert D. Weist
/S/ ROBERT J. WELTMAN Director June 13, 2000
---------------------------------
Robert J. Weltman
